Moderna Applies to US FDA for Booster Shot Use in All Adults

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Kim Suhwan] U.S. pharmaceutical company Moderna has applied to the U.S. Food and Drug Administration (FDA) to expand the eligibility for the COVID-19 vaccine booster shot to all adults aged 18 and over.

According to the New York Times (NYT) on the 17th (local time), Moderna submitted an application to the FDA for approval to use the COVID-19 vaccine booster shot for all adults.

Currently, in the United States, Moderna's COVID-19 vaccine booster shots are only available for seniors aged 65 and older and high-risk groups under 65.

According to Moderna, the booster shot dosage is 50 micrograms (㎍), which is half of the original 100 micrograms dosage.

Earlier, Pfizer-BioNTech also applied last week for booster shot use for all adults.

The FDA is expected to approve Pfizer's booster shot expansion application as early as the 18th, according to the NYT.

On the 19th, the U.S. Centers for Disease Control and Prevention (CDC) will hold an advisory committee meeting to discuss the expansion of booster shot use.

Meanwhile, with the possibility of a COVID-19 resurgence ahead of the cold winter, governments around the world are focusing on expanding booster shots.

Earlier, the European Union (EU) authorities approved the use of Moderna vaccine booster shots for all age groups last month.

This content was produced with the assistance of AI translation services.